There’s No Getting Around ARS Pharmaceuticals Inc (NASDAQ: SPRY) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

SPRY belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of ARS Pharmaceuticals Inc is $1.09B. A total of 2.11 million shares were traded on the day, compared to an average of 1.20M shares.

In the most recent transaction, Shawver Laura sold 50,000 shares of SPRY for 11.10 per share on Jan 06 ’25. After the transaction, the Director now owns 210,346 company shares. In a previous transaction on Jan 06 ’25, Shawver Laura bought 50,000 shares at 11.10 per share.

Among the insiders who sold shares, Tanimoto Sarina disposed of 100,000 shares on Dec 17 ’24 at a per-share price of $11.67. This resulted in the CHIEF MEDICAL OFFICER holding 1,098,499 shares of SPRY after the transaction. In another insider transaction, Lowenthal Richard E sold 100,000 shares at $11.67 per share on Dec 17 ’24. Company shares held by the PRESIDENT AND CEO now total 1,098,499.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SPRY has a high of $18.51 and a low of $5.74.

As of this writing, SPRY has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $0.26 per share and a lower estimate of -$0.31.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SPRY’s latest balance sheet shows that the firm has $60.06M in Cash & Short Term Investments as of fiscal 2021. There were $9.03M in debt and $8.19M in liabilities at the time. Its Book Value Per Share was $2.07, while its Total Shareholder’s Equity was -$31.27M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPRY is Buy with a score of 5.00.

Most Popular

Related Posts